Canopy Growth stock slides 3.55% as restatement of prior two years financials weighs

Traders Union
All News
Financial News
Canopy Growth slides 3.55% today

Highlights

Canopy Growth reported a 10% year-over-year net revenue increase to C$71.2 million, with substantial loss reduction to $0.17 per share for Q4 FY2026.
The company strengthened its balance sheet with a C$131.3 million cash position post-recapitalization, completed the MTL Cannabis acquisition, and maintained its lead in Canadian medical cannabis revenues.
Technicals signal ongoing downside as CGC/USD trades under key moving averages and momentum remains negative, with price likely to fluctuate between $0.91 and $1.02 in the near term.

Operating loss narrows and market share grows amid persistent selloff

Canopy Growth Corporation reported consolidated net revenue of C$71.2 million for Q4 FY2026, marking a 10% increase year over year and signaling improved operating performance. The company posted a quarterly loss of $0.17 per share, which narrowed significantly from the $0.94 per share loss a year earlier, while its year-end cash position stood at C$131.3 million following a recapitalization in January. Additionally, Canopy Growth completed its acquisition of MTL Cannabis, secured its lead in Canadian medical cannabis revenues, and restated financials for the prior two fiscal years, though price action has remained under broader selling pressure.

Downside momentum persists as oversold readings meet neutral trend

The price of CGC is now trading below the SMA-20 at $1.00, the SMA-50 at $1.02, and the SMA-200 at $1.20. The Ichimoku Kijun level at $1.01 is serving as immediate upside resistance. Momentum signals remain negative: MACD is in sell territory and the ADX is neutral, suggesting a lack of strong trend direction. Oscillators indicate oversold conditions, with an RSI of 38.39, as well as similarly low readings from the Stoch RSI and CCI, pointing to short-term selling fatigue. BBP confirms intraday seller dominance, while the Awesome Oscillator continues to support the downside move.

Sideways movement seen as upside chances remain limited

In the next 2 to 3 trading days, CGC is projected to fluctuate within the $0.91 to $1.02 range. The low probability of an upward move, presently at 21%, implies further downside remains more likely. The baseline expectation is for the price to move sideways inside this recent volatility band. A bullish scenario would require a break above $1.01 to signal recovery toward higher levels, while a failed defense of $0.91 support could suggest renewed downside momentum.

Anton Kharitonov, expert at Traders Union, sees clear operational progress from Canopy Growth Corporation but notes that core technicals remain negative. He believes that improved fundamentals have yet to override ongoing selling pressure, with key resistance levels still capping any recovery attempts. Until a convincing break above $1.01 materializes, the bias stays defensive. "Base case remains sideways to lower while price holds below resistance — I am waiting for a technical trigger before reassessing risk."

Earlier, analysts noted that Canopy Growth was exhibiting mixed momentum signals with a cautious outlook, highlighting persistent downside risks and a lack of strong directional cues. The latest financial improvements and ongoing technical pressure reinforce the view that sustained recovery will likely require a decisive move above immediate resistance levels, with further downside risk prevailing in the near term.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.